Repligen Corporation News
10 must-know biotech stock events to close out 2016
Important clinical trial results in Alzheimer's, cancer and Crohn's disease and a big FDA decision for Sarepta are expected before the end of the year.
Trade-Ideas: Repligen (RGEN) Is Today's Weak On High Relative Volume Stock
Trade-Ideas LLC identified Repligen (RGEN) as a weak on high relative volume candidate
Today's Dead Cat Bounce Stock Is Repligen (RGEN)
Trade-Ideas LLC identified Repligen (RGEN) as a "dead cat bounce" (down big yesterday but up big today) candidate
Insider Trading Alert - RGEN, DVA And FLT Traded By Insiders
Stocks with insider trader activity include RGEN, DVA and FLT
Trade-Ideas: Repligen (RGEN) Is Today's New Lifetime High Stock
Trade-Ideas LLC identified Repligen (RGEN) as a new lifetime high candidate
Breaking News
FTX Reportedly Close to Buying BlockFi
An acquisition could take several months to close, and the price could shift between now and Friday.
Morningstar's Five Coping Mechanisms for Bear Market
The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?
Economist Roubini: Why Stocks Poised for 50% Wipeout
The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.
Who Is the Mystery Crypto Queen on the Run After an Alleged Scam?
The FBI is offering anyone who helps arrest OneCoin co-founder Dr. Ruja Ignatova $100,000.